Unleashing anti-tumor immunity: Targeting the autophagy-related protein VPS34 to enhance STING agonist-based therapy
The release of CCL5 and CXCL10 is essential for recruiting cytotoxic immune cells into the tumor microenvironment and enhancing the efficacy of cancer immunotherapy. Type I IFNs, particularly IFNβ, activate signaling pathways that induce the expression of these chemokines. In our recent study, we ex...
Sparad:
| Huvudupphov: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Taylor & Francis Group
2024-12-01
|
| Serie: | Autophagy Reports |
| Ämnen: | |
| Länkar: | https://www.tandfonline.com/doi/10.1080/27694127.2024.2370728 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|